Lv2
148 积分 2022-08-23 加入
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1个月前
已完结
CAR T-cell therapy in autoimmune diseases
2个月前
已完结
Autoimmune disease is the next frontier for CAR T cell therapy
2个月前
已完结
Forks in the road for CAR T and CAR NK cell cancer therapies
2个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
3个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
3个月前
已完结
Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences
4个月前
已完结
Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing
4个月前
已完结
Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer
5个月前
已完结
Induction of immortal-like and functional CAR-T cells by defined factors
5个月前
已完结
皖公网安备34019202002308
